Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $80,000 of ALIGOS THERAPEUTICS INC. lobbying was just disclosed

None

$80,000 of ALIGOS THERAPEUTICS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Competition issues"

You can find more data on corporate lobbying on Quiver Quantitative.

ALGS Hedge Fund Activity

We have seen 15 institutional investors add shares of ALGS stock to their portfolio, and 15 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ALGS Analyst Ratings

Wall Street analysts have issued reports on $ALGS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • HC Wainwright & Co. issued a "Buy" rating on 09/12/2025

To track analyst ratings and price targets for ALGS, check out Quiver Quantitative's $ALGS forecast page.

ALGS Price Targets

Multiple analysts have issued price targets for $ALGS recently. We have seen 2 analysts offer price targets for $ALGS in the last 6 months, with a median target of $35.0.

Here are some recent targets:

  • Michael Yee from UBS set a target price of $20.0 on 01/07/2026
  • Patrick R. Trucchio from HC Wainwright & Co. set a target price of $50.0 on 09/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles